Health Management (HMA) Shares Rebound as Susquehanna Defends, Says Buy the Dip
Get Alerts HMA Hot Sheet
Price: $10.54 --0%
Rating Summary:
4 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
4 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Shares of Health Management Associates (NYSE: HMA) have bounced by more than 4 percent over the last hour of trade as Susquehanna's AJ Rice issued a mid-day note suggesting clients buy into Monday morning's weakness.
After trading to as low as $6.55 earlier, the stock is now down 8.5 percent to $6.85.
Shares were down more than 12 percent earlier on the heels of a CRT Capital report which considered a lawsuit from an ex-auditor who also happened to be an ex-FBI agent.
Susquehanna's Rice maintains a Positive rating and $11 price target on shares of Health Management Associates.
Visit our Analyst Ratings page to track all the market-moving analyst calls on shares of Health Management.
After trading to as low as $6.55 earlier, the stock is now down 8.5 percent to $6.85.
Shares were down more than 12 percent earlier on the heels of a CRT Capital report which considered a lawsuit from an ex-auditor who also happened to be an ex-FBI agent.
Susquehanna's Rice maintains a Positive rating and $11 price target on shares of Health Management Associates.
Visit our Analyst Ratings page to track all the market-moving analyst calls on shares of Health Management.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
Create E-mail Alert Related Categories
Analyst Comments, Momentum MoversRelated Entities
Susquehanna International Group of CompaniesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share